| A Case of Drug-induced Interstitial Lung Disease in a Patient withUlcerative Colitis Receiving Mesalamine |
|
Tae Hoon Lee, Suck-Ho Lee, Young-Sin Cho, Ji-Young Park, Jeong Hoon Park, Do Hyun Park, Il-Kwun Chung, Hong Soo Kim, Sang-Heum Park, Sun-Joo Kim, Mee-Hye Oh |
|
Division of Gastroenterology, Department of Internal Medicine, Pathology, Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
|
| Mesalamine 투여 중인 궤양성 대장염 환자에서 발생한약제 유발성 간질성 폐질환 1예 |
|
이태훈, 이석호, 조영신, 박지영, 박정훈, 박도현, 정일권, 김홍수, 박상흠, 김선주, 오미혜 |
|
순천향대학교 의과대학 천안병원 내과학교실, 병리학교실 |
|
|
| Abstract |
|
Pulmonary involvement in ulcerative colitis is very rare and may present as a variety of disorders. Pulmonary disease in patients with inflammatory bowel disease may be due to lung involvement in the disease itself or to drugs used for treatment, such as sulfasalazine or mesalamine. The use of mesalamine was initially thought to be free of adverse effects. Recently, however, pulmonary diseases related to the use of mesalamine have been reported. In this report, we describe a patient with ulcerative colitis and mesalamine induced interstitial lung disease. (Intest Res 2007;5:192-195) |
| Key Words:
Colitis, Ulcerative, Mesalamine, Lung Diseases, Interstitial |
|
PDF Links
Full text via DOI
Download Citation
